Gutierrez Martin相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

一项针对晚期胰腺癌或结直肠癌患者的BMS-813160（一种CCR2/5双重拮抗剂）联合化疗或纳武利尤单抗的1b/2期研究

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2024-011284

Le, Dung T; Folprecht, Gunnar; Varghese, Anna M; Gutierrez, Martin; Noel, Marcus; Trikalinos, Nikolaos A; Chen, Eric; Dayyani, Farshid; Davis, S Lindsey; Ma, Wen Wee; BasuMallick, Atrayee; Garrido-Laguna, Ignacio; Osawa, Mayu; O'Brien, Shaun; Novosiadly, Ruslan D; Xu, Ke; Greenawalt, Danielle M; Dutta, Santanu; Twyman Saint Victor, Christina; Lenz, Heinz-Josef

多发性硬化症

发表日期：2026

文献求助收藏

Feasibility and Acceptability of Symptom Management Research in Black Advanced Lung Cancer Patients

针对黑人晚期肺癌患者开展症状管理研究的可行性和可接受性

期刊:Journal of Pain and Symptom Management

影响因子:3.5

doi:10.1016/j.jpainsymman.2025.08.026

Conley, Claire C; Mossman, Brenna; Aduloju, Ayomide; Billini, Osairys M; Slossar, Joie; Khoudary, Amanda; Rodriguez, Jennifer D; Kim, Chul; Wheeley, Jennifer; Gutierrez, Martin; Derry-Vick, Heather

发表日期：2026

文献求助收藏

"A lot of the times, patients really don't know what questions to ask:" Communication perspectives of Black patients with advanced lung cancer

“很多时候，患者真的不知道该问什么问题：” 晚期肺癌黑人患者的沟通视角

doi:10.1016/j.pec.2026.109569

AuBuchon, Katarina E; Aduloju, Ayomide; Billini, Osairys M; Khoudary, Amanda; Rodriguez, Jennifer D; Kim, Chul; Wheeley, Jennifer; Gutierrez, Martin; Derry-Vick, Heather M; Conley, Claire C

发表日期：2026

文献求助收藏

Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B

PD-1 和 TIM-3 联合靶向治疗局部晚期或转移性非小细胞肺癌患者：AMBER 第二部分 B

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-25-0806

Davar, Diwakar; Eroglu, Zeynep; Milhem, Mohammed; Becerra, Carlos; Gutierrez, Martin; Ribas, Antoni; Di Pace, Brian; Wang, Tianli; Zhang, Hailei; Ghosh, Srimoyee; Yanamandra, Niranjan; Borgovan, Theo; Srivats, Shyam; Waszak, Angela; Dhar, Arindam; LoRusso, Patricia

细胞生物学

发表日期：2025

文献求助收藏

First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors

首次人体 I 期开放标签研究，评估抗 TIM-3 单克隆抗体 INCAGN02390 对特定晚期或转移性实体瘤患者的疗效

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyaf144

Gutierrez, Martin E; Tang, Shou-Ching; Powderly, John D 2nd; Balmanoukian, Ani S; Hoyle, Paul E; Dong, Zhiwan; Cheng, Lulu; Gong, Xiaohua; Janik, John E; Bourayou, Nawel; Hamid, Omid

单克隆抗体

发表日期：2025

文献求助收藏

First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors

首次人体 I 期开放标签研究，评估 LAG-3 拮抗剂抗体 INCAGN02385 在特定晚期或转移性实体瘤患者中的疗效

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyaf136

Powderly, John D 2nd; Gutierrez, Martin E; Balmanoukian, Ani S; Hoyle, Paul E; Dong, Zhiwan; Cheng, Lulu; Chen, Xuejun; Janik, John E; Bourayou, Nawel; Hamid, Omid

发表日期：2025

文献求助收藏

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors

Zilovertamab Vedotin治疗转移性实体瘤患者的II期研究

期刊:Cancer Research Communications

影响因子:3.3

doi:10.1158/2767-9764.CRC-25-0019

Meric-Bernstam, Funda; Gutierrez, Martin; Sanz-Garcia, Enrique; Villa, Diego; Zhang, Jun; Friedmann, Jennifer; Yan, Fengting; Socinski, Mark A; Sarantopoulos, John; Raez, Luis E; Chu, Quincy S; Chénard-Poirier, Maxime; Chatterjee, Manash S; Ren, Hong; Liu, Qi; Levine, Douglas A; Jhaveri, Komal L

发表日期：2025

文献求助收藏

Shared decision making in routine oncology appointments with Black patients with lung cancer

在与患有肺癌的黑人患者的常规肿瘤科就诊中，共同制定决策

期刊:Supportive Care in Cancer

doi:10.1007/s00520-025-09300-4

AuBuchon, Katarina E; Khoudary, Amanda; Rodriguez, Jennifer D; Billini, Osairys M; Westervelt, Isabella; Taylor, Emily P; Newton, Noelle; Emenyonu, Melody; Kim, Chul; Veystman, Irina; Wheeley, Jennifer; Gutierrez, Martin; Derry-Vick, Heather M; Conley, Claire C

发表日期：2025

文献求助收藏

Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors

一项开放标签的 Ia 期研究，评估 STING 激动剂 BI 1703880 联合 ezabenlimab 治疗晚期实体瘤患者的疗效。

期刊:Future Oncology

影响因子:2.6

doi:10.1080/14796694.2024.2441107

Harrington, Kevin; Kitano, Shigehisa; Gambardella, Valentina; Parkes, Eileen E; Moreno, Irene; Alonso, Guzman; Doi, Toshihiko; Berz, David; Gutierrez, Martin E; Fernandez, Natalia; Schmohl, Michael; Barrueco, José; LoRusso, Patricia

发表日期：2025

文献求助收藏

IGF2BP3 remodels the microRNA targeting landscape in MLL-AF4 leukemia

IGF2BP3 重塑 MLL-AF4 白血病中的 microRNA 靶向图谱

doi:10.1101/2025.10.10.681741

Kabbani, Lyna E S; Kapoor, Shruti; Sharma, Gunjan; Gutierrez, Martin; Neeb, Zachary T; Jaiswal, Amit Kumar; Ritter, Alexander J; Katzman, Sol; Feldman, Jordyn; Rao, Dinesh S; Sanford, Jeremy R

发表日期：2025

文献求助收藏